Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-59

You've assumed a linear growth of recruitment. The past recruitment reports should show you that is not the case. Mt Sinai have been slow, but with multiple sites it was always going to be a exponential growth, taking perhaps a month to properly prepare each site for the very strict protocols of application a rigidly run randomised controlled trial across multiple sites was always going to require.

We had the first patients dosed on 5 May. The 30% recruitment didnt come late August, but we've 50% now in early October. Clearly its an exponential type recruitment curve. It will be done in December.

Everyone seems to have forgotten EAP of REM-L for MIS-C in kids too. There is going to be mounting evidence to push REM-L through for emergency approval in COIVD-19 related deaths sooner than later.